Feb 14, 2015 - Oral antifungal prophylaxis with azoles, such as fluconazole or itraconazole, is preferentially used in pediatric patients after chemotherapy.
Eur J Clin Microbiol Infect Dis (2015) 34:1189–1200 DOI 10.1007/s10096-015-2340-y
ARTICLE
Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia M. Döring & M. Eikemeier & K. M. Cabanillas Stanchi & U. Hartmann & M. Ebinger & C.-P. Schwarze & A. Schulz & R. Handgretinger & I. Müller
Received: 20 November 2014 / Accepted: 26 January 2015 / Published online: 14 February 2015 # The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract Pediatric patients with hemato-oncological malignancies and neutropenia resulting from chemotherapy have a high risk of acquiring invasive fungal infections. Oral antifungal prophylaxis with azoles, such as fluconazole or itraconazole, is preferentially used in pediatric patients after chemotherapy. M. Döring (*) : K. M. Cabanillas Stanchi : M. Ebinger : C.
